| Market Cap | ₹8,739Cr |
| ROE | 15.22% |
| P/E Ratio(TTM) | 58.51 |
| EPS(TTM) | 3.42 |
| P/B Ratio | 10.33 |
| Dividend Yield | 0.00% |
| Industry P/E | 32.40 |
| Book Value | 19.37 |
| Debt to Equity | 0.61 |
| Face Value | 2 |
| Managing Director | Mr. Rajaram Narayanan |
| Founded | 1985 |
| NSE Symbol | VIYASH |
| FUND NAME | AUM(%) |
|---|---|
| UTI Healthcare Fund Direct Growth | 2.11% |
| Quant Small Cap Fund Direct Plan Growth | 1.67% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 44.20 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 30.63 | ||
| Wockhardt | NA (0.00%) | -2112.90 | ||
| Natco Pharma | NA (0.00%) | 11.01 |